<h3>The Opportunity</h3><p><a href="https://himalayas.app/companies/futuresight">FutureSight</a> is seeking a Co-Founder &amp; CEO to lead <a href="https://concordance-futuresight.vercel.app/" rel="nofollow ugc noopener noreferrer" class="external" target="_blank">Concordance</a>, an AI-native clinical documentation compliance venture. This is a co-founder partnership with meaningful founder equity, not a salaried executive role.</p><p><a href="https://concordance-futuresight.vercel.app/" rel="nofollow ugc noopener noreferrer" class="external" target="_blank">Concordance </a>AI audits 100% of healthcare charts in real-time, catches payer-specific gaps before they hit billing, and eliminates the manual QA overhead that costs organizations millions in denials and clawbacks every year. Currently, manual QA teams consume 25%+ of operational labour budgets, yet audit only about 10% of patient charts, leaving organizations massively exposed.</p><h3>Market Context</h3><p>We didn't just build a thesis; we validated it directly with the market. We have spoken directly with Compliance Directors, QA Leaders, and Revenue Cycle Directors across behavioural health organizations. The market signal is incredibly strong:</p><ul><li>Unprompted Product Pull: Every single lead described the exact product we want to build: a pre-billing, real-time, EHR-integrated flagging layer that checks documentation against payer-specific rules before claims are submitted.</li><li>Massive Financial Pain: The real pain comes from post-payment recoupments (clawbacks). Buyers cited chronic, aggressive payer audits happening weekly or monthly, with single audit events causing catastrophic losses ranging from $150,000 to $850,000.</li><li>Budget is NOT the Blocker: Buyers explicitly stated that if the tool integrates cleanly with their EHR and meets a high accuracy bar, securing the budget is not a problem.</li></ul><p>We are targeting a large, highly fragmented market where revenue cycle teams are increasingly struggling to manage denials at scale. The total addressable market is estimated at $4.0B–$6.0B+, spanning more than 20,000 organizations, including multispecialty groups, behavioural health providers, and health systems. The ROI case is compelling: at current price points, the software can quickly pay for itself by reducing manual auditing labour by an estimated 80–85% while also preventing clawbacks that translate into millions in avoided losses.</p><h3>About <a href="https://himalayas.app/companies/futuresight">FutureSight</a></h3><p><a href="https://himalayas.app/companies/futuresight">FutureSight</a> is a leading venture builder that co-creates world-class software companies with values-driven entrepreneurs from inception to exit. We are a team of founders, operators and designers with experience successfully bringing software to market at scale.</p><p>You’ll co-create with a proven studio team, led by John Carbrey (4x entrepreneur, $100M ARR), Krista LaRiviere (3x exited,